Analyst consensus rating
Adicet Bio Analyst Rating: Strong Buy
ACET is rated Strong Buy by 6 analysts with a $33.17 target. As of 2026-08-21.
Direct answer
Adicet Bio's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $33.17.
Forecast evidence checked August 21, 2026.
Get free Adicet Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.19
- Average price target
- $33.17
- High price target
- $90.00
- Low price target
- $18.00
- Low target gap
- +95.9%
- Target upside
- +260.9%
- High target gap
- +879.3%
- Target range width
- 783.5%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Adicet Bio?
Adicet Bio has a verified Strong Buy consensus. The same dataset has an average price target of $33.17.
How far are Adicet Bio's low and high targets from the recorded price?
The low target implies +95.9%, while the high target implies +879.3%.
How many analysts are included in Adicet Bio's consensus?
The verified consensus includes 6 analysts.
How is Adicet Bio's target upside or downside calculated?
The average target of $33.17 is divided by the recorded price of $9.19, then one is subtracted to produce +260.9%. This does not guarantee a future return.
When was Adicet Bio's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.